Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.

about

HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings [Quality of life and AIDS from the perspective of persons living with HIV: a preliminary contribution by the structural approach to social representations].

P2860

Q28088839-B64EB5BD-F038-4156-8E8E-E4EBD83489C1 Q41438260-2693A737-9702-4AD5-AEAC-EE99946BB7D7

P2860

Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.

Item

http://www.wikidata.org/entity/Q43586525

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Body changes: antiretroviral t ...... n people living with HIV/AIDS.

@en

Body changes: antiretroviral t ...... n people living with HIV/AIDS.

@nl

type

Item

label

Body changes: antiretroviral t ...... n people living with HIV/AIDS.

@en

Body changes: antiretroviral t ...... n people living with HIV/AIDS.

@nl

prefLabel

Body changes: antiretroviral t ...... n people living with HIV/AIDS.

@en

Body changes: antiretroviral t ...... n people living with HIV/AIDS.

@nl

P1476

Body changes: antiretroviral t ...... in people living with HIV/AIDS

@en

P2093

Ana Paula Morais Fernandes

http://www.w3.org/2001/XMLSchema#string

Mariana Machado da Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.

Facial lipoatrophy: appearances are not deceiving.

Risk factors in human immunodeficiency virus/acquired immunodeficiency syndrome patients undergoing antiretroviral therapy in the state of Pernambuco, Brazil: a case-control study.

A randomized clinical trial to evaluate the effect of diet on weight loss and coping of people living with HIV and lipodystrophy.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

P304

847-853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0104-11692012000500005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alcyone Artioli Machado

L C Tsuda

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233750252

http://www.w3.org/2001/XMLSchema#string

P698

23174828

http://www.w3.org/2001/XMLSchema#string

Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.

about

P2860

P2860

Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698